.Nature Medication, Published online: 16 September 2024 doi:10.1038/ s41591-024-03244-8In the observational SCRUM-Japan GOZILA research study, after a mean consequence of 11 months, individuals along with metastatic stomach lumps who obtained biomarker-matched treatments based upon spreading lump DNA profiling showed a higher professional benefit than those receiving unequaled treatment.